News

/News/

Las Vegas CES2019 Highlights

The Consumer Electronics Show (CES2019) dazzled participants once again with glimpses of technologies and products on the horizon for the future.  With over 180,000 attendees from 150 different countries, circulating over 11 venues throughout Las Vegas. Optalert’s key conversations at this year’s event included autonomous vehicles, enhanced ‘early warning’ drowsiness and distraction features, and AI assisting in remote healthcare technology. Optalert’s Chief Technical Officer Simon Block, shares some of his top highlights for the show:    1. Automotive Innovation Intelligent cars dominated the conversation in the automotive market, with seamless connectivity critical [...]

By |2019-01-17T14:05:06+00:00January 17th, 2019|Automotive, Pharmaceutical|

Keep your holidays happy by being vigilant on the roads this year.

The holiday season is the time of the year when impaired and drowsy driving accidents are most prevalent. Many of us would never imagine that a holiday celebration could result in a fatality or imprisonment.  The risks associated with driving while drowsy are very real.  Driving performance can be impaired, reaction times increase and it could result in tragic consequences for everyone involved. The Drowsy Driving Problem Drowsy driving usually happens when a driver has not slept enough, but it can also happen due to drinking alcohol, untreated sleep disorders, [...]

By |2018-12-20T10:51:32+00:00December 20th, 2018|Automotive|

Introducing the BlinQ system by Optalert

Optalert is pleased to introduce the BlinQ system for the measurement of drowsiness or wakefulness in clinical trials. Optalert uses advanced patented algorithms to determine the exact drowsiness or wakefulness of a subject.  By applying Artificial Intelligence techniques and machine learning Optalert has been able to objectively quantify drowsiness or wakefulness.  Utilising the Johns Drowsiness Scale (JDS), Optalert's future-proofed approach can advance clinical drug trial timelines and deliver new therapies to market faster. Current methodologies for measuring drowsiness or wakefulness are used across a wide range of clinical drug trials including anti-depressants, shift-work disorder, narcolepsy [...]

By |2018-12-17T15:50:16+00:00December 17th, 2018|Pharmaceutical|

Challenges of pharmaceutical companies

Pharmaceutical companies face many challenges, with hundreds of new drugs required to transition through clinical trial phases, regulatory processes and to market, more quickly and more efficiently. The Centre for the Study of Drug Development (CSDD) estimates the cost of developing a prescription drug that gains market approval at $2.6 billion. Even more remarkable is that 90% of medicines that start being tested in people don’t reach the market because they are unsafe or ineffective. “May cause drowsiness” This is a common warning label on [...]

By |2018-11-08T10:52:12+00:00November 2nd, 2018|Pharmaceutical|

5 of the greatest technological discoveries in the medical field

Every technological discovery aims to improve our health, safety, and quality of life. Every day, we marvel over exciting new developments that emerge from each corner of the globe. A few weeks ago, we looked at seven of the most significant pharmacological discoveries, and this week, we want to expand our exploration into great technology that help diagnose or treat disease and improve health. As we find ourselves increasingly immersed in advanced digital technology, we’re introduced to new discoveries that sound almost as if they came straight out of a [...]

By |2018-10-11T13:08:24+00:00October 10th, 2018|Pharmaceutical|

From ESS to the JDS: Dr Murray Johns’ drowsiness detection technology enters the pharmaceutical industry

Optalert revolutionises pharmaceutical research with in-clinic test for wakefulness. Richmond, VIC: Optalert is pleased to introduce its latest wakefulness detection technology to the pharmaceutical industry for use during clinical drug trials. Optalert’s technology enhances clinical testing by offering pharmaceutical researchers an objective, measurable and real-time scale of drowsiness in addition to the alternative wakefulness, common outcomes and/or side effects measured in pharmaceutical drug trials. A highly sensitive LED camera fitted in Optalert’s glasses tracks eyelid movement, speed and blink frequency at a rate of 500 times per second. Results are [...]

By |2018-10-11T13:06:00+00:00September 11th, 2018|Pharmaceutical|

What’s involved in a pharmaceutical trial?

It is estimated global pharmaceutical company Johnson and Johnson employs more than 127,000 people. And in the US alone more than 800,000 people work in the pharmaceutical industry developing, testing, and producing drugs for a range of medical ailments. From vaccinations and Insulin to contraception, each medication must face scrutiny and assessment through vigilant testing and trials. Side effects and health risks are assessed through various trial stages. Once a drug is approved for use, it is then marketed and sold. Fast facts about the pharmaceutical industry The industry achieved [...]

By |2018-10-11T13:06:11+00:00August 19th, 2018|Pharmaceutical|

7 of the greatest pharmacological discoveries in the health industry

As science and medicine progresses, the research community has had an incredible effect on life expectancy and I’ve looked at seven of the greatest discoveries to impact human health. ALS/MND breakthroughs Year discovered: 2016 and 2017 Remember the ALS Ice Bucket Challenge that flooded social media back in 2014? The impact was huge: People shared more than 1.2 million Ice Bucket Challenge videos on Facebook It received more than 2.2 million mentions on Twitter Wikipedia’s ALS page grew from an average of 160,000 views per month to 2.89 million in [...]

By |2018-10-11T13:06:26+00:00July 31st, 2018|Pharmaceutical|

Measuring drowsiness in clinical trials

Using Optalert’s Johns Drowsiness Scale (JDS), various studies and trials have accurately measured a user’s state of alertness and drowsiness. In the study below, first published in 2008, we understand the effect of caffeine on already-alert people using the precision and sensitivity of Optalert’s patented JDS technology. By identifying a direct link to human alertness, we gain a quantifiable measure of wakefulness, literally putting a number on how drowsy or alert you are (not just how alert or tired you may feel). Publication: Michael, N., Johns, M., Owen, C, Patterson, [...]

By |2018-09-27T15:41:05+00:00August 24th, 2017|Pharmaceutical|

Diagnosing the dangers of drowsiness

Companies working in 24-hour industries face a number of challenges related to the health and welfare of their staff. The risk of a fatigue-related incident is most commonly attributed to a driver’s levels of drowsiness, but there are other factors, too. Shift workers particularly are prone to sleep disorders and other lifestyle and medical challenges that may harm their ability to always perform at their peak. The most common question we hear from industry is “how do we know if we have a problem and how large that problem may [...]

By |2018-09-27T21:10:44+00:00August 3rd, 2017|Goods & Passenger Transport|
Translate » Language